Search clinical trials for: metastatic castration resistant prostate cancer, BRCA1, BRCA2, ATM, Homologous recombination repair
Total 27383 results
-
Massachusetts General HospitalCompletedBreast Cancer | BRCA1 Mutation | BRCA2 MutationUnited States
-
Southwest Oncology GroupNational Cancer Institute (NCI)CompletedBreast Cancer | brca1 Mutation Carrier | brca2 Mutation CarrierUnited States
-
NYU Langone HealthWithdrawnBreast Cancer | BRCA1 Mutation | BRCA2 MutationUnited States
-
University of Alabama at BirminghamNational Cancer Institute (NCI)WithdrawnOvarian Cancer | brca1 Mutation Carrier | brca2 Mutation CarrierUnited States
-
University of ArizonaNational Cancer Institute (NCI)CompletedOvarian Cancer | brca1 Mutation Carrier | brca2 Mutation CarrierUnited States
-
University College London HospitalsCompletedBreast Cancer | Hereditary Breast/Ovarian Cancer (brca1, brca2) | brca1 Mutation Carrier | brca2 Mutation CarrierAustralia, Israel, United Kingdom, Spain, Sweden, Portugal
-
Assistance Publique - Hôpitaux de ParisUnknownBreast Neoplasms | BRCA1 Protein | BRCA2 Protein | TomosynthesisFrance
-
Centre Oscar LambretCTD-CNO; Laboratoire PRISMActive, not recruitingBRCA1 Mutation | BRCA2 Mutation | Hereditary Breast and Ovarian CancerFrance
-
University of PennsylvaniaUnited States Department of DefenseCompleted
-
National Human Genome Research Institute (NHGRI)CompletedBreast CancerUnited States
-
Catholic University of the Sacred HeartUnknownBRCA1 and BRCA2 Mutation Carrier and BRCAness PhenotypeItaly
-
National Human Genome Research Institute (NHGRI)TerminatedBreast Cancer | Ovarian Neoplasm | Cancer GeneticsUnited States
-
Centre Francois BaclesseCompletedHereditary Breast and Ovarian Cancer SyndromeFrance
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)WithdrawnBreast Carcinoma | BRCA1 Mutation Carrier | BRCA2 Mutation CarrierUnited States
-
Georgetown UniversityNational Cancer Institute (NCI)Completed
-
City of Hope Medical CenterNational Cancer Institute (NCI)Active, not recruitingBreast Cancer | brca1 Mutation Carrier | brca2 Mutation CarrierUnited States
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)UnknownBreast Cancer | brca1 Mutation Carrier | brca2 Mutation CarrierUnited States
-
PfizerMedivation, Inc.CompletedBreast Neoplasms | BRCA 1 Gene Mutation | BRCA 2 Gene MutationKorea, Republic of, United States, Australia, Spain, Belgium, France, Ireland, Taiwan, Poland, Germany, Israel, Brazil, United Kingdom, Italy, Russian Federation, Ukraine
-
PfizerMedivation, Inc.; Myriad Genetic Laboratories, Inc.TerminatedBreast Neoplasms | BRCA 1 Gene Mutation | BRCA 2 Gene MutationUnited States, Spain, United Kingdom, Germany, France
-
Royal Marsden NHS Foundation TrustCompletedMRI | BRCA1 Mutation | BRCA2 Mutation | MammographyUnited Kingdom
-
Institute of Cancer Research, United KingdomRoyal Marsden NHS Foundation Trust; Cancer Research UK; Ronald and Rita McAulay...Active, not recruitingProstate Cancer in BRCA1 and BRCA2 CarriersUnited Kingdom
-
Centre Jean PerrinInternational Cancer Research Group; Institut Max Planck d'optique quantiqueRecruitingBRCA1 Mutation | BRCA2 Mutation | Breast Cancer FemaleFrance
-
Hadassah Medical OrganizationUnknownBRCA1 Gene Mutation | BRCA2 Gene MutationIsrael
-
National Cancer Institute (NCI)Recruiting
-
Vejle HospitalAbbottCompletedRecurrent, Epithelial Ovarian CancerDenmark
-
University of MichiganNational Cancer Institute (NCI)CompletedOvarian Cancer Risk | Risk-reducing Surgery | Fallopian Tube Fimbriae | Ovarian Cortical Inclusion CystsUnited States, Canada
-
Columbia UniversityAmerican Cancer Society, Inc.CompletedBreast Cancer | Ovarian Cancer | BRCA1 Mutation | BRCA2 MutationUnited States
-
Georgetown UniversityNational Cancer Institute (NCI); National Human Genome Research Institute (NHGRI)CompletedBreast Cancer | Hereditary Breast/Ovarian Cancer (brca1, brca2)United States
-
The Cleveland ClinicNational Cancer Institute (NCI)CompletedBreast Cancer | Hereditary Breast/Ovarian Cancer (brca1, brca2)
-
Dana-Farber Cancer InstituteMedical University of South Carolina; National Cancer Institute (NCI); Massachusetts... and other collaboratorsCompletedBreast Cancer | Ovarian CancerUnited States
-
Institut CurieRecruitingGenetic Predisposition | Gene Mutation-Related CancerFrance, Guadeloupe, Martinique, Réunion
-
Abramson Cancer Center at Penn MedicineActive, not recruitingAdvanced Breast Cancer | Metastatic Breast Cancer | BRCA1 Mutation | BRCA2 Mutation | Locally Advanced Breast CancerUnited States
-
Rabin Medical CenterUnknownLynch Syndrome | BRCA1 Syndrome | BRCA2 SyndromeIsrael
-
Institute of Cancer Research, United KingdomRecruitingProstate CancerUnited Kingdom
-
Massachusetts General HospitalRecruitingLynch Syndrome | Genetic Predisposition to Disease | Prostate Cancer | BRCA1 Mutation | BRCA2 Mutation | Prostatic Neoplasm | ATM Gene Mutation | MMR MutationUnited States
-
Georgetown UniversityCompletedPancreatic Cancer | Breast Neoplasm | BRCA1 Mutation | BRCA2 Mutation | Prostate CarcinomaUnited States
-
Chang Gung Memorial HospitalIntuitive SurgicalActive, not recruitingBreast Cancer | BRCA1 Mutation | BRCA2 Mutation | Nipple-sparing Mastectomy | Prophylactic MastectomyTaiwan
-
European Organisation for Research and Treatment...AstraZenecaWithdrawnBRCA1 Mutation | BRCA2 Mutation | TNBC - Triple-Negative Breast Cancer
-
AstraZenecaMerck Sharp & Dohme LLC; Myriad Genetic Laboratories, Inc.Active, not recruitingBreast Cancer Metastatic | BRCA 1 Gene Mutation | BRCA 2 Gene MutationItaly, Spain, United States, Czechia, Romania, France, Korea, Republic of, United Kingdom, Hungary, Japan, Peru, Poland, Russian Federation, Turkey, China, Taiwan, Bulgaria, Switzerland, Mexico
-
The University of Texas Health Science Center at...WithdrawnOvarian Cancer | Breast Cancer Stage IV | BRCA1 Mutation | BRCA2 Mutation
-
VA Office of Research and DevelopmentRecruitingMetastatic Castrate Resistant Prostate Cancer | BARD1, BRCA1, BRCA2, BRIP1, CHEK1, FANCL, PALB2 | RAD51B, RAD51C, RAD51D, or RAD54L MutationsUnited States
-
University Medical Center NijmegenRecruitingOvarian Cancer | BRCA1 Gene Mutation | BRCA2 Gene Mutation | RAD51C Gene Mutation | RAD51D Gene Mutation | BRIP1 Gene MutationNetherlands, United States, Belgium, Norway, Poland, Italy, Australia, Mexico, Brazil, Sweden, Uruguay
-
Nerviano Medical SciencesActive, not recruitingAdvanced/Metastatic Solid TumorsUnited States, United Kingdom, China, Italy, Bulgaria, Hungary
-
Fondazione Policlinico Universitario Agostino Gemelli...Completed
-
Hellenic Cooperative Oncology GroupActive, not recruitingProstate Cancer Recurrent | Prostate Cancer Metastatic | Mutation | Germline BRCA1 Gene Mutation | Germline BRCA2 Gene MutationGreece
-
AstraZenecaActive, not recruitingBreast | Prostate | Ovarian | Pancreatic | Advanced TumoursSweden, Spain, Israel, Australia, Germany
-
AstraZenecaCompletedOvarian CancerUnited Arab Emirates
-
Jiangxi Qingfeng Pharmaceutical Co. Ltd.UnknownBreast Cancer Metastatic | BRCA 1 Gene Mutation | BRCA 2 Gene MutationChina
-
Institute of Cancer Research, United KingdomCancer Research UK; National Institute for Health Research, United KingdomRecruitingProstate Cancer | BRCA1 Mutation | BRCA2 MutationUnited Kingdom